COMP <GO>
CHPT vs ULBI // ENTERPRISE SCALE & MARKET CAP
ChargePoint Holdings Inc. (NYSE) VS. Ultralife Corporation (NASDAQ) • 15-METRIC TALLY: CHPT 1
— ULBI 8
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ULBI
LAST: $9.54 (+2.91%) • MKT CAP: $248.9M
market-cap
$248.9M
LAST: $15.62 (0.00%) • MKT CAP: $260.3M
market-cap
$260.3M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHPT VS. ULBI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHPT | ULBI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.50% | 24.10% | +6.40 | CHPT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -2.80% | -32.20 | ULBI | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 2.73% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -51.10% | -3.10% | -48.00 | ULBI | /operating-margins <GO> |
| Net Profit Margin | -53.50% | -3.10% | -50.40 | ULBI | /net-margins <GO> |
| Revenue Growth (YoY) | -1.40% | 16.20% | -17.60 | ULBI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 2.71 | -2.51 | ULBI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | ULBI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.3 | 93.4 | -34.10 | ULBI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $248.9M | $260.3M | -$11.4M | ULBI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHPT REV | ULBI REV | CHPT GROSS % | ULBI GROSS % | CHPT FCF | ULBI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $411.2M | $191.2M | 30.5% | 24.1% | -$67.0M | $7.1M |
| FY 2024 | $417.1M | $164.5M | 24.1% | 25.7% | -$159.0M | $14.7M |
| FY 2023 | $506.6M | $158.6M | — | — | -$328.9M | $1.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHPT // BETA —
ULBI // BETA —